$3.45
-0.04 (-1.15%)
Antigenics, Inc. (NASDAQ:AGEN)
CAPS Rating:
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.